Filter posts

BioGENEius – From Student Participant to Judge

It’s been two years since I participated as a student in BioGENEius. Last year I …

The Affordable Care Act is Here to Stay

The Patient Protection and Affordable Care Act (ACA) of 2010 includes provisions that could lead …

Debt, Taxes and Politics: Is There a Way Out?

BIO President and CEO Jim Greenwood kicked off a keynote discussion with Sen. Alan Simpson …

Spotlight on China

The 20th annual BIO International Convention is wrapping up in Chicago. Experts and leaders from …

The Rise of Specialty Pharmaceuticals

Fact: Specialty pharmaceuticals represented nearly 25 percent of all drug spending last year. By 2018, …

State of the Biotech Industry: Burrill's Biotech 2013 Report

To open his Super Session at the 2013 BIO International Convention, G. Steven Burrill, CEO …

Scientific American Worldview

The fifth annual edition of Scientific American Worldview explores ongoing challenges and opportunities in the …

Protect Yourself from a Hack Attack

Gone are the days when biotech’s biggest activist threats came from lab break-ins and physical …

The Ethics of the Market Access Debate

At the core of the market access conversation lies the question of value. How much …

Managed Entry Trumps Risk Sharing

Since 2000, pharmaceu-tical and biotech companies have engaged in agreements with government and private payers …